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Abstract
Aims: To develop methods to disaggregate World Health Orgagnization estimates of tu-
berculosis (TB) incidence and mortality for each country by sex and age.
Methods: For countries where incidence estimates derived from a factor adjustment of
notifications and case detection ratio over 0.85, or with <1000 reported TB cases, we dis-
aggregated incidence proportional to notifications. For each other country, a prior was
constructed using a hierarchical model of age-stratified prevalence survey data, meta-
analysis of sex ratios, and mathematical modelling for children under 15 years. Samples
from this prior were used to disaggregate incidence and accepted if incidence exceeded
notifications in each age/sex category. Results were inspected and, if implausible, inci-
dence was disaggregated proportional to notifications. Mortality was disaggregated pro-
portional to patterns in vital registration (VR) data in countries with VR data. Where VR
data were lacking, a case-fatality ratio (CFR) approach was applied to estimated inci-
dence, with separate CFRs by HIV/ART status, child/adult age groups, and anti-TB treat-
ment status. Uncertainty in all disaggregated country estimates was constructed to be
consistent with corresponding overall uncertainty.
Results: We generated disaggregated results for 216 countries. For 125 countries, inci-
dence disaggregation was based on notifications. Of the rest, accepted samples from the
prior were considered implausible in 4 countries. For 72 countries, mortality disaggrega-
tion was based on VR data; the rest were based on the CFR approach.
Conclusions: While multi-stage, this approach is comparatively simple in overall logic.
Disaggregated estimates have relatively larger uncertainty and should be used with
caution.
Introduction
Despite modest declines in global incidence, tuberculosis
(TB) remains the world’s leading cause of death from a sin-
gle pathogen.1 The tuberculosis monitoring and evaluation
unit of the Global TB programme at the World Health
Organization (WHO) undertakes a yearly analysis of data
supplied by its member states to generate estimates of TB
burden in each state, regionally and globally. These esti-
mates are released after a country consultation process as
part of the WHO annual Global Tuberculosis Report,
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which provides analysis for the previous year.1 Estimates
of TB disease burden are used to monitor progress towards
targets as part of the End TB strategy, as well as to provide
evidence on the scale and distribution of TB to inform in-
tervention strategies and investment cases.
TB incidence estimation is necessary, as sample size and
expense preclude general population surveys of TB inci-
dence. In some settings with strong surveillance systems, the
majority of TB cases are diagnosed and reported and notifi-
cation data are a close approximation to underlying inci-
dence. In such settings, a common ‘standard factor’
adjustment is applied to scale up notifications to incidence
(unless an inventory study can inform a local factor).
However, in many settings, under-diagnosis and under-
reporting each contribute to a substantial gap between un-
derlying incidence and notifications, amounting to approxi-
mately2 million cases globally in 2018.1 Data from TB
prevalence surveys and inventory studies of under-reporting
of detected TB cases, as well as expert opinion based on epi-
demiological assessments, inform TB incidence estimates in
these settings. Similarly civil and vital registration systems
provide direct data on the number of TB deaths, but these
are not available for many countries. For these countries, in-
direct estimates of TB mortality are based on estimates of
the case fatality ratio (CFR) in different groups. The meth-
ods used for these estimates are described in the Global
Tuberculosis Report and its technical appendix.1,2
There is an increasing demand for more finely-grained
estimates of TB burden, stratified by age group and sex, to
identify under-served groups and tailor public health strategy
to local epidemiology. For example, data from surveillance
and prevalence surveys suggest that TB burden is higher in
men in most settings.3 In some settings a high burden of TB is
born by older age groups,4 whereas in many high-burden set-
tings, children under 15 are thought to be relatively under-di-
agnosed.5 Since 2017, Global Tuberculosis Reports have
generated estimates of TB incidence and mortality disaggre-
gated by age and sex for the most recent year.1,6,7 This builds
on previous work reporting estimates for children separately
from adults, first included in the 2012 report,8 and for which
specific adjustment and modelling approaches handle the rel-
atively larger gap between incidence and notifications for
children under 15years of age, thought to exist in many
settings.5,9,10
This article details the current approach used to gener-
ate age- and sex-disaggregated estimates of TB incidence
and mortality for the Global Tuberculosis Report.1
Methods
We developed a methodology to disaggregate estimates of
tuberculosis incidence and mortality by sex and age
categories: 0–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64
and 65þ years, and applied it to the most recent year’s data
(here 2018). To ensure consistency with envelope uncer-
tainty, age- and sex-stratified variances split country-level
variances in proportion to each stratum point estimate.
Incidence disaggregation
To disaggregate tuberculosis incidence, we followed three
steps, guided by estimated case detection ratio (CDR, the
ratio of notifications to estimated incidence).
1) For countries where either:
(i) standard factor adjustment was used to estimate tu-
berculosis incidence and CDR >0.85;
(ii) a capture-recapture study was used to estimate tuber-
culosis incidence and CDR >0.85; or
(iii) fewer than 1000 tuberculosis cases were reported in
total;
we disaggregated total tuberculosis incidence by age and
sex in proportion to the notifications.
These countries were those with either strongly performing
surveillance systems that could reliably inform on patterns
by age and sex, or those where the epidemic is small enough
for true patterns to be driven by stochastic and import
effects, making modelled predictions less appropriate. We
used the most recent age-disaggregated notification data if
the previous year’s data were unavailable as follows.
2) We drew 1 million samples from a country prior for the
proportion of tuberculosis incidence in each age and sex
category (see next section for details). Samples were ac-
cepted if they yielded incidence higher than notifications
in every category or, if no samples met this criterion, the
1% of samples with the smallest sum of squared under-
shoots was used (undershoots being those differences
between incidence and notifications which are negative).
We then disaggregated according to the mean propor-
tions accepted samples.
3) For countries where the results from 2) above were
judged implausible based on inconsistency with notifica-
tion data (e.g. undershoots) or feedback from country
experts, we disaggregated in proportion to notifications.
To visually assess outputs, we checked plots for each
country of incidence and notifications by age and sex.
Construction of priors
The prior probability distributions for the proportion of
tuberculosis in each age and sex category in each country
were constructed based on tuberculosis prevalence survey
















































































data, systematic review and modelling of paediatric
incidence.
The prior for the proportion of adult incidence in each age
category was based on a Bayesian hierarchical model of prev-
alence survey data stratified by WHO region. In total, we
used 24 nationally representative TB prevalence surveys since
2010 which reported bacteriologically confirmed TB preva-
lence (with confidence intervals) for age categories 15–24,
25–34, 35–44, 45–54, 55–64 and 65þ years. For each region,
the logarithmic relative risk of tuberculosis prevalence in
each age category (with appropriate sample uncertainty) was
modelled as a multivariate normal with a regional normal
inverse-Wishart prior. This enabled meta-analytical predic-
tions for countries in a region without surveys, and more pre-
cise and local estimates for countries with survey data.
More formally, we took the observed vector zi of loga-
rithmic relative risks by age in country i (where
i ¼ 1; . . . ;n), to be distributed zi  MVNðyi;EiÞ, where Ei
is a specified diagonal variance matrix with elements deter-
mined by the confidence intervals associated with each ele-
ment of zi, and where the mean yi is the underlying vector
of true logarithmic relative risks by age in country i. We
modelled yi as multivariate normal:
yi  MVNðl;RÞ;
with a shared normal inverse-Wishart prior across each re-
gion, i.e.
l;R  NIWðl0; k;W; Þ:
The normal inverse-Wishart is conjugate to the multi-
variate normal distribution so that the conditional distribu-
tion for l;RjY (where Y ¼ fyig
n
i¼1) is also normal inverse-
Wishart, with new parameters l00; k
0;W0; 0 determined by a
standard update rule.11 We sampled from the overall
model using a Gibbs sampling scheme that alternated this
step updating the distribution l;RjY with a step sampling
Yjl;R;Z (where Z ¼ fzig
n
i¼1). This second update can also













The split of tuberculosis incidence between male and fe-
male adults (MF ratio) was based on Horton et al.’s sys-
tematic review and meta-analysis of tuberculosis sex-
ratios.3 The age-controlled relative risk of TB by sex in a
country was numerically solved to match the meta-analysis
sex ratio for the corresponding WHO region (or the
country-specific MF ratio if informed by prevalence survey
data), once weighted by adult demographic patterns.
In more detail: let rs be the underlying relative TB risk
for sex s 2 ff ;mg for females and males, respectively (tak-
ing females as the reference category), and qa be the under-
lying relative TB risk for age category a (relative to 15–
24 year olds), and model relative risk age a and sex s multi-
plicatively as rsqa. With Na;s the population in a country
for age category a and sex s, the observed marginal relative
risks RRa for age a and MF (the male: female prevalence











where Na and Ns are the total number of people in this
country for age category a and sex s, respectively. In gen-
eral, MF will be somewhat different from rm and RRa
somewhat different from qa. We numerically solved these
equations for rm and qa given MF and RRa, and evaluated
the joint proportion of adult TB cases in age category a





The prior fraction of all tuberculosis incidence among
children under 15, and the fraction among children under
5, were sampled from a previous approach to paediatric tu-
berculosis estimation based on modelling transmission
from adults and progression to disease,5 using updated in-
put data. The sex splits in 0–4 and 5–14 age groups were
based on a WHO region-stratified random effects meta-
analysis of the ratios in the most recent notification data.
Mortality disaggregation
As with incidence, disaggregating mortality for a country
depended on the approach used to estimate total tubercu-
losis mortality in that country. For countries whose VR
data were rated high and medium quality for the
Sustainable Development Goal,12 the proportion of deaths
recorded in each age and sex category was used to disag-
gregate estimated deaths. For International Classification
of Diseases (ICD)-10, codes A15-A19 and B90 were used;
for ICD-9, codes 010–018 and 137 were used.
For countries where estimates of total tuberculosis mor-
tality were based on a case-fatality ratio (CFR) approach,
the disaggregation of estimated mortality used a CFR-
based estimate of the proportion of deaths in each age- and
sex-category. For countries with CFR-based estimates of
mortality, literature estimates of CFR stratified by human
















































































immunodeficiency virus (HIV), antiretroviral treatment
(ART) and TB treatment status were used to estimate sepa-
rately tuberculosis mortality among HIV-uninfected and
HIV-infected individuals.
For children aged <15 years, we used a previously pub-
lished CFR approach to estimate tuberculosis mortality in
children,13 stratifying CFR by age (0–4 and 5–14 years)
and TB treatment status (estimated from estimated inci-
dence and notifications), based on systematic review,14 in
addition to HIV, ART status. This enabled estimation of
the fraction of all tuberculosis deaths occurring in children
aged <15 years, and by age category, sex and HIV status.
For adults (aged 15þ years), separate CFRs were used for
HIV-infected and HIV-uninfected individuals, which were
assumed to be constant across all adult age groups and
both sexes.
To visually assess outputs, we checked plots for each
country of the fraction of tuberculosis mortality in each
age and sex group.
Results
In this article, we report results from intermediate steps in
the analysis and relevant to illustrating the performance of
the methodology. The main results are reported in the
WHO Global Tuberculosis Report 2019 and associated
data.1
Hierarchical model of prevalence survey data
The regionally stratified hierarchical model of age patterns
used in constructing our incidence prior generated predic-
tions that followed patterns in available country data,
slightly pulling predictions towards the regional mean (see
Figure 1a and b for results for the WHO Africa region).
The predictions for counties in a region without survey
data reflected a weighted mean, and the larger uncertainty
intervals captured most survey data (see Figure 1c).
Notification sex ratios in children under 15 years
A random effects meta-analysis of the fraction of notifica-
tions by sex for those those aged under 5 years used in con-
structing our incidence prior found 54.5% [95%
confidence interval (CI) 53.7%, 55.4%] and [95% predic-
tion interval (PI) 48.6%, 60.3%] reported cases were male.
For cases aged 5–14 years, 49.5% (95% CI 48.7%,
50.4%) and (95% PI 42.6%, 56.5%) cases were male. A
random-effects meta-regression using WHO region as an
explanatory variable found these fractions were consistent
across regions, see Table 1.
Incidence results
In total, we disaggregated tuberculosis incidence for 216
countries. For 125 countries (13% of global incidence),
this used notification data (Method 1). Of these: 28 coun-
tries (13.0% of global incidence) had incidence estimates
based on standard factor adjustment and CDR >0.85; two
countries (4.1% of incidence) had incidence estimates
based on inventory studies and had CDR >0.85; and 95
countries (0.2% of global incidence) had fewer than 1000
tuberculosis reported cases in total. (We classed countries
as having fewer than 1000 reported tuberculosis cases if
they also met another criterion for Method 1.)
For 89 countries (53.5% of global incidence), this was
based on the prior/rejection approach (Method 2). For
three countries (0.2% of global incidence)—South Sudan,
Syrian Arab Republic, Togo—disaggregated estimates
Figure 1 Hierarchical model of TB prevalence survey data in the WHO
Africa region. Prediction (posterior median) and uncertainty bands (95%
credible interval) from fitted hierarchical model for countries with sur-
veys: A) Ethiopia, B) Zambia; and C) for countries in this region without
data
















































































were based on samples where incidence undershot notifica-
tions in at least one age and sex category.
Method 3: for four countries—Bangladesh, India,
Myanmar, Democratic People’s Republic of Korea—(33.5% of
global incidence), we reverted to a standard factor adjustment,
based on the implausibility of outputs from Method 2. The
prior struggled to reflect observed sex ratio (India, Bangladesh)
and/or predicted insufficient incidence among younger adults
(Bangladesh, India, Myanmar, Democratic People’s Republic
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Case fatality ratio approach
B
Figure 2 Map of methods used for disaggregation of TB incidence (A) and mortality (B). Colours represent method (described in text). Dots mark
countries with a recent national TB prevalence survey whose data has been used in the hierarchical model prior
Table 1 Fraction of TB notifications among males for children under 15 years. Central estimates and 95% prediction intervals
from random effects meta-regression with WHO region as covariate, and without covariates for the global result
WHO region Fraction male: age 0-4 years
(95% prediction interval)
Fraction male: age 5-14 years
(95% prediction interval)
AFR 0.534 (0.488, 0.591) 0.497 (0.430, 0.565)
AMR 0.543 (0.488, 0.596) 0.485 (0.415, 0.555)
EMR 0.550 (0.495, 0.604) 0.475 (0.406, 0.546)
EUR 0.522 (0.466, 0.577) 0.507 (0.437, 0.577)
SEA 0.569 (0.515, 0.621) 0.508 (0.437, 0.578)
WPR 0.566 (0.488, 0.591) 0.499 (0.429, 0.570)
Global 0.545 (0.486, 0.603) 0.495 (0.426, 0.565)
The WHO regions are AFR ¼ Africa, AMR ¼ The Americas, EMR ¼ Eastern Mediterranean, EUR ¼ Europe, SEA ¼ South-East Asia, WPR ¼ Western Pacific
















































































IJE online) for plots comparing incidence disaggregation results
byMethods 2 and 3 for these countries.
Figure 2a shows the method used for incidence disag-
gregation in each country. Figure 3a and b shows incidence
estimates and notifications by age and sex group, aggre-
gated at global and WHO region level, respectively.
Mortality results
In total, we disaggregated tuberculosis mortality for 216 coun-
tries. For 72 countries (4.3% of global HIV-negative TBmortal-
ity), mortality disaggregation was based on VR data. For 117
countries (95.4% of global HIV-negative TBmortality), mortal-
ity disaggregation was based on the CFR approach. For 27
countries, (0.3% of global HIV-negative TB mortality), mortal-
ity disaggregation was based on regional average patterns.
Figure 2b shows the method used for mortality disag-
gregation in each country. Figure 3c and d shows estimated
mortality fractions in each age and sex group, aggregated
at global and WHO region level, respectively.
Discussion
This article describes a methodology for disaggregating na-
tional estimates of TB incidence and mortality by age and
sex. This has evolved over the past 3 years,1,6,7 and the
process presented here corresponds to that used for burden
estimates in the 2019 Global Tuberculosis Report.1
Methods are likely to evolve in the future, responding to
new evidence, data and identified shortcomings.
The methods presented here do not fall within a single
formal statistical framework, but do adhere to a set of
principles. The first is to make use of robust, local surveil-
lance data wherever possible. WHO member states provide
input data, and expect it to be reflected in country esti-
mates. Therefore, where country VR data are available,
020 20 40
0100200 100 200 300
0 200 400200400
20 4020 0 4040 0 80
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500 0 500 1500
Figure 3 Global and regional aggregate patterns of TB incidence (panels A and B; x-axes in thousands per year, y-axes show age groups in years) and
TB mortality (panels C and D; y-axes show the proportion of deaths in each age group, x-axes show the proportion of deaths in each sex within each
age group). Red (left) represents females; green (right) represents men
















































































mortality disaggregation has been based on these. Where
the estimated gap between incidence and notifications is
comparatively small, the disaggregation of incidence has
been based on this. Where this gap is larger, however, noti-
fications may not be a reliable guide to relative burden in
each age group and identifying comparatively under-served
groups necessitates alternative approaches.
The second principle is to seek to maintain simplicity
and transparency. The variety in epidemiological patterns,
surveillance biases and data completeness across 216 coun-
tries make this challenging. We prefer explicit use of ad
hoc approaches (e.g, the third step of the incidence disag-
gregation approach) to rigid adherence to a formalism
whose outputs lack credibility and buy-in among those us-
ing them or providing the data on which they are based.
Last, we require estimates and their associated uncer-
tainty to be robust and consistent. Whereas estimates
should reflect true trends and inevitably shift with method-
ological innovation and new evidence, robustness means
that estimates should not be unduly sensitive and fluctuate
over time or between rounds without clear justification.
Consistency requires that aggregating estimates and uncer-
tainty across countries and any set of categories generates
results that match estimates at the aggregate level. Building
up total estimates from each subcategory is in principle
possible, but category-specific supporting data are more of-
ten lacking. We enforced consistency under a disaggrega-
tion approach—modelling estimates in each category and
their uncertainty as a proportion of each country’s total.
This is similar to disaggregation of mortality estimates
across causes of death, where the total envelope is known
more accurately than individual causes.
Our approach considers each country and TB incidence and
TB mortality separately, and does not guarantee consistency of
relationships between quantities or locations. This contrasts
with the approach used by the Institute of Health Metrics and
Evaluation (IHME), who estimate TB incidence and mortality
by age, sex and country within a single meta-analytical frame-
work alongside health burdens due to other causes.15 Their ap-
proach may allow more efficient inference from the available
data by borrowing strength across measures, causes and loca-
tions, but makes it harder to explain specific results where data
are sparse. IHME global estimates are similar in pattern to
WHO estimates for incidence, but have higher proportions of
deaths in older age groups (see Appendix), presumably reflect-
ing stronger weighting for patterns in VR data. Estimates of TB
burden from the Global TB Department of WHO feed into the
Global Health Observatory data produced by the WHO and
associated World Health Statistics reports.12,16 These include a
range of causes of morbidity and mortality, and may require
adjustments to disease-specific causes to reconcile totals with
envelopes.
This approach has many limitations. These include
the principle that incidence should exceed notifications;
in some countries and age categories over-diagnosis is
possible, particularly when the proportion of bacterio-
logically confirmed cases is low and there is over-
reliance on clinical diagnosis. The childhood notification
data suffer from serious limitations, including inconsis-
tencies in applied diagnostic criteria: some notified cases
may have been wrongly diagnosed as childhood TB
cases, and under-reporting of detected cases and under-
diagnosis remain common where access to quality health
services is lacking. The prior for adult age patterns is
based on prevalence data; differential duration of disease
may mean these are biased with respect to incidence pat-
terns. Furthermore, our prior did not allow interactions
between sex and age patterns, and adult CFRs for
untreated TB did not vary by age or sex. CFRs for
untreated TB may increase with age, which would mean
our assumption under-estimates TB deaths in older age
groups. Last, we have not considered within-country het-
erogeneity; subnational correlations in relevant quantities
could bias estimates in either direction.
Anticipated updates to this process include producing
disaggregated estimates for all years and additional dis-
aggregation for age groups 5–14 and 15–24. These age
groups reflect traditional groupings for TB notification
data, but 5-year splits would allow easier comparison
with other estimates and are relevant to an increased
emphasis on adolescent health.17–19 Evidence on case fa-
tality rates by age and sex would be helpful for coun-
tries using a CFR approach to mortality disaggregation.
Data from six new national prevalence surveys during
2019–29 are expected, including India, and will be in-
corporated into the hierarchical model for age pattern
priors.
For estimates such as these, the smaller the population,
the larger the relative uncertainty, implying that age-,
country- and sex-specific estimates should be interpreted
with caution and not used for target setting. However,
these estimates may serve as a guide in identifying popula-
tion groups with higher burden or poorer case detection
which warrant further attention for investigation or inter-
vention. Ultimately, the best way to improve estimates of
disease burden is through strengthened surveillance and
reporting systems, including development of civil and vital
registration systems.
Supplementary data
Supplementary data are available at IJE online.
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